As the number of uninsured people in the US continues to rise, insurance companies tightening the screws--which they take more seriously now than ever-- and with the general public wise to the ways of obtaining cheaper meds, I think the immediate future looks murky for "Big Pharma." BMY is now considering recalling Serzone from the Canadian market because of liver-damage problems. Drug companies are under pressure from all sides. Exactly when they will be good investments again is anyone's guess.